StockNews.com began coverage on shares of Arcadia Biosciences (NASDAQ:RKDA – Free Report) in a research report report published on Saturday morning. The brokerage issued a sell rating on the basic materials company’s stock.
Arcadia Biosciences Stock Performance
Shares of NASDAQ:RKDA opened at $3.88 on Friday. The company has a market cap of $5.30 million, a P/E ratio of -0.91 and a beta of 0.35. Arcadia Biosciences has a one year low of $1.96 and a one year high of $10.31. The business’s 50-day simple moving average is $3.26 and its 200 day simple moving average is $4.18.
Arcadia Biosciences (NASDAQ:RKDA – Get Free Report) last posted its earnings results on Thursday, May 8th. The basic materials company reported $1.90 EPS for the quarter, topping analysts’ consensus estimates of ($0.98) by $2.88. The business had revenue of $1.20 million for the quarter, compared to analysts’ expectations of $1.60 million. Arcadia Biosciences had a negative net margin of 110.61% and a negative return on equity of 52.63%.
Institutional Trading of Arcadia Biosciences
Arcadia Biosciences Company Profile
Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.
Recommended Stories
- Five stocks we like better than Arcadia Biosciences
- What Are Dividend Achievers? An Introduction
- Constellation Powers Up With Reinforced AI Data Center Strategy
- Retail Stocks Investing, Explained
- Top Analyst-Rated Healthcare Stocks to Watch Now
- How to Buy Gold Stock and Invest in Gold
- GlobalFoundries Stock Hits Bottom: Is a Rebound Coming?
Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.